IL-17A-Producing Foxp3+ Regulatory T Cells and Human Diseases

키워드

참고문헌 (82)

1. Curiel TJ, "Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival", Nat Med, 10, pp.942~949 (2004)
2. Ehrenstein MR, "Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy", J Exp Med, 200, pp.277~285 (2004)
3. Kriegel MA, "Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II", J Exp Med, 199, pp.1285~1291 (2004)
4. Miyara M, "Global natural regulatory T cell depletion in active systemic lupus erythematosus", J Immunol, 175, pp.8392~8400 (2005)
5. Viglietta V, "Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis", J Exp Med, 199, pp.971~979 (2004)
6. Barbi J, "Treg functional stability and its responsiveness to the microenvironment", Immunol Rev, 259, pp.115~139 (2014)
7. Beriou G, "IL-17-producing human peripheral regulatory T cells retain suppressive function", Blood, 113, pp.4240~4249 (2009)
8. Du R, "IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells", J Leukoc Biol, 96, pp.39~48 (2014)
9. Duarte JH, "Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions", Eur J Immunol, 39, pp.948~955 (2009)
10. Hovhannisyan Z, "Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases", Gastroenterology, 140, pp.957~965 (2011)
11. Pesenacker AM, "Control of tissue-localized immune responses by human regulatory T cells", Eur J Immunol, 45, pp.333~343 (2015)
12. Voo KS, "Identification of IL-17-producing FOXP3+ regulatory T cells in humans", Proc Natl Acad Sci U S A, 106, pp.4793~4798 (2009)
13. Whibley N, "Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge", Eur J Immunol, 44, pp.1069~1083 (2014)
14. Joller N, "Good guys gone bad: exTreg cells promote autoimmune arthritis", Nat Med, 20, pp.15~17 (2014)
15. Komatsu N, "Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis", Nat Med, 20, pp.62~68 (2014)
16. Zhou X, "Plasticity of CD4(+) FoxP3(+) T cells", Curr Opin Immunol, 21, pp.281~285 (2009)
17. Stock P, "Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity", Nat Immunol, 5, pp.1149~1156 (2004)
18. Josefowicz SZ, "Regulatory T cells: mechanisms of differentiation and function", Annu Rev Immunol, 30, pp.531~564 (2012)
19. Sakaguchi S, "Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease", J Exp Med, 161, pp.72~87 (1985)
20. Sakaguchi S, "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases", J Immunol, 155, pp.1151~1164 (1995)
21. Abbas AK, "Regulatory T cells: recommendations to simplify the nomenclature", Nat Immunol, 14, pp.307~308 (2013)
22. Hori S, "Control of regulatory T cell development by the transcription factor Foxp3", Science, 299, pp.1057~1061 (2003)
23. Vignali D., "How many mechanisms do regulatory T cells need?", Eur J Immunol, 38, pp.908~911 (2008)
24. Bhaskaran N, "TLR-2 signaling promotes IL-17A production in CD4+CD25+Foxp3+ regulatory cells during oropharyngeal candidiasis", Pathogens, 4, pp.90~110 (2015)
25. Hori S., "Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells", Immunol Rev, 259, pp.159~172 (2014)
26. Miyao T, "Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells", Immunity, 36, pp.262~275 (2012)
27. Cosmi L, "Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor", J Exp Med, 205, pp.1903~1916 (2008)
28. Kleinewietfeld M, "The plasticity of human Treg and Th17 cells and its role in autoimmunity", Semin Immunol, 25, pp.305~312 (2013)
29. Koenen HJ, "Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells", Blood, 112, pp.2340~2352 (2008)
30. Maggi L, "CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC", Eur J Immunol, 40, pp.2174~2181 (2010)
31. Miyara M, "Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor", Immunity, 30, pp.899~911 (2009)
32. Miyara M, "Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans", Proc Natl Acad Sci U S A, 112, pp.7225~7230 (2015)
33. Afzali B, "CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner", Eur J Immunol, 43, pp.2043~2054 (2013)
34. Leveque L, "Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells", J Immunother, 32, pp.101~108 (2009)
35. Li L, "IL-1β-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells", J Immunol, 185, pp.4148~4153 (2010)
36. Yang XO, "Molecular antagonism and plasticity of regulatory and inflammatory T cell programs", Immunity, 29, pp.44~56 (2008)
37. Xu L, "Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta", J Immunol, 178, pp.6725~6729 (2007)
38. Osorio F, "DC activated via dectin-1 convert Treg into IL-17 producers", Eur J Immunol, 38, pp.3274~3281 (2008)
39. Li J, "Regulatory role of CD4(+)CD25 (+)Foxp3 (+) regulatory T cells on IL-17-secreting T cells in chronic hepatitis B patients", Dig Dis Sci, 59, pp.1475~1483 (2014)
40. Nylander A, "Multiple sclerosis", J Clin Invest, 122, pp.1180~1188 (2012)
41. Ishii KJ, "Host innate immune receptors and beyond: making sense of microbial infections", Cell Host Microbe, 3, pp.352~363 (2008)
42. Uematsu S, "Toll-Like receptors (TLRs) and their ligands", Handb Exp Pharmacol, 1(20), pp.1~20 (2008)
43. Caramalho I, "Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide", J Exp Med, 197, pp.403~411 (2003)
44. Gelman AE, "Toll-like receptor ligands directly promote activated CD4+ T cell survival", J Immunol, 172, pp.6065~6073 (2004)
45. Jin B, "The effects of TLR activation on T-cell development and differentiation", Clin Dev Immunol, 2012, pp.836485~ (2012)
46. Komai-Koma M, "TLR2 is expressed on activated T cells as a costimulatory receptor", Proc Natl Acad Sci U S A, 101, pp.3029~3034 (2004)
47. Liu H, "Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells", Proc Natl Acad Sci U S A, 103, pp.7048~7053 (2006)
48. Oberg HH, "Regulation of T cell activation by TLR ligands", Eur J Cell Biol, 90, pp.582~592 (2011)
49. van Maren WW, "Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation", BMC Immunol, 12, pp.23~ (2011)
50. Hoffmann P, "Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation", Eur J Immunol, 39, pp.1088~1097 (2009)
51. Netea MG, "Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells", J Immunol, 172, pp.3712~3718 (2004)
52. Nyirenda MH, "TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function", J Immunol, 187, pp.2278~2290 (2011)
53. Sutmuller R, "Regulatory T cells and toll-like receptors: regulating the regulators", Ann Rheum Dis, 66(Suppl 3), pp.iii91~iii95 (2007)
54. Pasare C, "Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells", Science, 299, pp.1033~1036 (2003)
55. Chen W, "Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3", J Exp Med, 198, pp.1875~1886 (2003)
56. Korn T, "IL-17 and Th17 cells", Annu Rev Immunol, 27, pp.485~517 (2009)
57. McGeachy MJ, "T cells doing it for themselves: TGF-beta regulation of Th1 and Th17 cells", Immunity, 26, pp.547~549 (2007)
58. Zhou L, "TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function", Nature, 453, pp.236~240 (2008)
59. Chaudhry A, "Control of inflammation by integration of environmental cues by regulatory T cells", J Clin Invest, 123, pp.939~944 (2013)
60. Chaudhry A, "CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner", Science, 326, pp.986~991 (2009)
61. Pandiyan P, "Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells", Cytokine, 76, pp.13~24 (2015)
62. Golden JB, "IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities", Cytokine, 62, pp.195~201 (2013)
63. Sugiyama H, "Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation", J Immunol, 174, pp.164~173 (2005)
64. Bovenschen HJ, "Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin", J Invest Dermatol, 131, pp.1853~1860 (2011)
65. Sanchez Rodriguez R, "Memory regulatory T cells reside in human skin", J Clin Invest, 124, pp.1027~1036 (2014)
66. Zhang L, "Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity", Clin Immunol, 135, pp.108~117 (2010)
67. Arpaia N, "Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation", Nature, 504, pp.451~455 (2013)
68. Cebula A, "Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota", Nature, 497, pp.258~262 (2013)
69. Cong Y, "A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota", Proc Natl Acad Sci U S A, 106, pp.19256~19261 (2009)
70. Kryczek I, "17+ regulatory T cells in the microenvironments of chronic inflammation and cancer", J Immunol, 186, pp.4388~4395 (2011)
71. Li L, "The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer", Clin Immunol, 148, pp.246~253 (2013)
72. Ueno A, "Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients", Inflamm Bowel Dis, 19, pp.2522~2534 (2013)
73. Pesenacker AM, "CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines", Blood, 121, pp.2647~2658 (2013)
74. Pesenacker AM, "T regulatory cells in childhood arthritis--novel insights", Expert Rev Mol Med, 15, pp.e13~ (2013)
75. McClymont SA, "Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes", J Immunol, 186, pp.3918~3926 (2011)
76. Jandus C, "Selective accumulation of differentiated FOXP3(+) CD4 (+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood", Cancer Immunol Immunother, 57, pp.1795~1805 (2008)
77. Ye J, "Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function", Eur J Immunol, 41, pp.936~951 (2011)
78. Saito T, "Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers", Nat Med, 22, pp.679~684 (2016)
79. Whibley N, "Brothers in arms: Th17 and Treg responses in Candida albicans immunity", PLoS Pathog, 10, pp.e1004456~ (2014)
80. Hernández-Santos N, "Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections", Mucosal Immunol, 6, pp.900~910 (2013)
81. Pandiyan P, "CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model", Immunity, 34, pp.422~434 (2011)
82. Zhang M, "Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states", J Infect Dis, 205, pp.1111~1120 (2012)

관련 논문AI추천